Monoclonal remyelination-promoting natural autoantibody SCH 94.03: Pharmacokinetics and in vivo targets within demyelinated spinal cord in a mouse model of multiple sclerosis

Journal of the Neurological Sciences

Volumn 150, Issue 2, 1997, Pages 103-113

  Hunter, Samuel F ^a   Miller, David J ^a   Rodriguez, Moses ^a  

^a MAYO CLINIC   (United States)

Author keywords

Demyelination; Multiple sclerosis; Myelin; Natural autoantibody; Oligodendrocyte; Pharmacokinetics; Remyelination; Theiler's virus

Indexed keywords

AUTOANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEMYELINATION; FEMALE; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; REMYELINIZATION; SPINAL CORD; ULTRASTRUCTURE;

ANIMALS; ANTIBODIES, MONOCLONAL; AUTOANTIBODIES; AXONS; BRAIN; FEMALE; MICE; MICE, INBRED STRAINS; MODELS, BIOLOGICAL; MULTIPLE SCLEROSIS; MYELIN SHEATH; OLIGODENDROGLIA; POLIOMYELITIS; SPINAL CORD; THEILOVIRUS; TISSUE DISTRIBUTION;

EID: 0030752967     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(97)00080-4     Document Type: Article

References (38)

1. Asakura K., Miller D.J., Murray K., Bansal R., Pfeiffer S.E. and Rodriguez M. (1996) Monoclonal autoantibody SCH94.03, which promotes central nervous system remyelination, recognizes an antigen on the surface of oligodendrocytes J. Neurosci. Res. 43: 273-281.
2. Asakura K., Pogulis R., Pease L.R. and Rodriguez M. (1996) A monoclonal autoantibody which promotes central nervous system remyelination is highly polyreactive to multiple known and novel antigens J. Neuroimmunol. 65: 11-19.
3. Avrameas S. and Ternynck T. (1993) The natural autoantibodies system: between hypotheses and facts Mol. Immunol. 30: 1133-1142.
4. Bansal R. and Pfeiffer S.E. (1989) Reversible inhibition of oligodendrocyte progenitor differentiation by a monoclonal antibody against surface galactolipids Proc. Natl. Acad. Sci. USA 86: 6181-6185.
5. Bansal R., Gard A.L. and Pfeiffer S.E. (1988) Stimulation of oligodendrocyte differentiation in culture by growth in the presence of a monoclonal antibody to sulfated glycolipid J. Neurosci. Res. 21: 260-267.
6. Benjamins J.A. and Dyer C.A. (1990) Glycolipids and transmembrane signaling in oligodendroglia Ann. NY Acad. Sci. 605: 90-100.
7. Brown, D.A., Stumpf, W.E., Diab, I.M. and Roth, L.J. (1969) Assessment of autoradiographic resolution using soluble extracellular indicators. In: Roth, C.J. Stumpf, W.E. (Eds.), Autoradiography of Diffusible Substances. Academic Press, New York.
8. Cohen J.A., Williams W.V., Weiner D.B., Geller H.M. and Greene M.I. (1990) Ligand binding to the cell surface receptor for reovirus type 3 stimulates galactocerebroside expression by developing oligodendrocytes Proc. Natl. Acad. Sci. USA 87: 4922-4926.
9. Dyer C.A. and Benjamins J.A. (1988) Antibody to galactocerebroside alters organization of oligodendroglial membrane sheets in culture J. Neurosci. 8: 4307-4318.
10. 2+ responses in oligodendrocytes J. Neurosci. Res. 30: 699-711.
11. Dyer C.A., Hickey W.F. and Geisert Jr. E.E. (1991) Myelin/oligodendrocyte-specific protein: a novel surface membrane protein that associates with microtubules J. Neurosci. Res. 28: 607-613.
12. Gibaldi, M. (1984) Biopharmaceutics and Clinical Pharmacokinetics, 3rd ed. Lea & Febiger, Philadelphia, 330 pp.
13. Haunschild J., Steiner K., Faro H.-P. and Senekowitsch R. (1995) Pharmacokinetics of reshaped MAb 425 in three animal species Cell Biophys. 26: 167-182.
14. Hunter S.F. and Bottenstein J.E. (1989) Bipotential glial progenitors are targets of neuronal cell line-derived growth factors Brain Res. Dev. Brain Res. 49: 33-49.
15. Hunter S.F. and Bottenstein J.E. (1990) Growth factor responses of enriched bipotential glial progenitors Brain Res. Dev. Brain Res. 54: 235-248.
16. Hunter S.F. and Bottenstein J.E. (1991) O-2A glial progenitors from mature rat brain respond to CNS neuronal cell line-derived growth factors J. Neurosci. Res. 28: 574-582.
17. Hunter S.F. and Rodriguez M. (1995) Multiple sclerosis: a unique immunopathological syndrome of the central nervous system Springer Semin. Immunopathol. 17: 89-105.
18. Lehrer G.M., Maker H.S., Silides D.J., Weiss C. and Bornstein M.B. (1979) Stimulation of myelin lipid synthesis in vitro by white matter antiserum in absence of complement Brain Res. 172: 557-560.
19. Miller D.J. and Rodriguez M. (1995) A monoclonal autoantibody that promotes central nervous system remyelination in a model of multiple sclerosis is a natural autoantibody encoded by germline immunoglobulin genes J. Immunol. 154: 2460-2469.
20. Miller D.J. and Rodriguez M. (1995) Spontaneous and induced remyelination in multiple sclerosis and the Theiler's virus model of central nervous system demyelination Microsc. Res. Tech. 32: 230-245.
21. Miller D.J. and Rodriguez M. (1996) Spontaneous central nervous system remyelination in strain A mice after infection with the Daniel's (DA) strain of Theiler's virus Acta Neuropathol. 91: 559-565.
22. Miller D.J., Sanborn K.S., Katzmann J.A. and Rodriguez M. (1994) Monoclonal autoantibodies promote central nervous system repair in an animal model of multiple sclerosis J. Neurosci. 14: 6230-6238.
23. Miller D.J., Rivera-Quinones C., Njenga M.K., Leibowitz J. and Rodriguez M. (1995) Spontaneous CNS remyelination in beta-2-microglobulin-deficient mice following virus-induced demyelination J. Neurosci. 15: 8345-8352.
24. Miller D.J., Njenga M.K., Murray P.D., Leibowitz J. and Rodriguez M. (1996) A monoclonal natural autoantibody that promotes remyelination suppresses central nervous system inflammation and increases virus expression after Theiler's virus-induced demyelination Int. Immunol. 8: 131-141.
25. Miller D.J., Njenga M.K., Parisi J.E. and Rodriguez M. (1996) Multi-organ reactivity of a monoclonal natural autoantibody that promotes remyelination in a mouse model of multiple sclerosis J. Histochem. Cytochem. 44: 1005-1011.
26. Patick A.K., Thiemann R.L., O'Brien P.C. and Rodriguez M. (1991) Persistence of Theiler's virus infection following promotion of central nervous system remyelination J. Neuropathol. Exp. Neurol. 50: 523-537.
27. Prineas J.W., Barnard R.O., Revesz T., Kwon E.E., Sharer L. and Cho E.S. (1993) Multiple sclerosis. Pathology of recurrent lesions Brain 116: 681-693.
28. Reilly R.M., Sandhu J., Alvarez-Diez T.M., Gallinger S., Kirsch J. and Stern H. (1995) Problems of delivery of monoclonal antibodies: pharmaceutical and pharmacokinetic solutions Clin. Pharmacokinet. 28: 126-142.
29. Rodriguez M. and Lennon V.A. (1990) Immunoglobulins promote remyelination in the central nervous system Ann. Neurol. 27: 12-17.
30. Rodriguez M., Lennon V.A., Benveniste E.N. and Merrill J.E. (1987) Remyelination by oligodendrocytes stimulated by antiserum to spinal cord J. Neuropathol. Exp. Neurol. 46: 84-95.
31. Rodriguez M., Oleszak E. and Leibowitz J. (1987) Theiler's murine encephalomyelitis: a model of demyelination and persistence of virus CRC Crit. Rev. Immunol. 7: 325-365.
32. Rodriguez M., Scheithauer B.W., Forbes G. and Kelly P.J. (1993) Oligodendrocyte injury is an early event in lesions of multiple sclerosis Mayo Clin. Proc. 68: 627-636.
33. Rodriguez M., Prayoonwiwat N., Howe C. and Sanborn K. (1994) Proteolipid protein gene expression in demyelination and remyelination of the central nervous system: a model for multiple sclerosis J. Neuropathol. Exp. Neurol. 53: 136-143.
34. Rodriguez M., Miller D.J. and Lennon V.A. (1996) Immunoglobulins reactive with myelin basic protein promote CNS remyelination Neurology 46: 538-545.
35. Rogers, A.W. (1979) Techniques of Autoradiography. Elsevier, New York.
36. Traugott U. (1987) Multiple sclerosis: relevance of class I and class II MHC-expressing cells to lesion development J. Neuroimmunol. 16: 283-302.
37. Valentine J.L. and Hunter S.F. (1985) INTRAV and ORAL: BASIC interactive computer programs for estimating pharmacokinetic parameters J. Pharm. Sci. 74: 113-119.
38. Wagner, J.G. (1971) Pharmacokinetics and relevant biopharmaceutics. Drug Intelligence Publications, Hamilton, IL, pp. 322-324.